Year: 2023

LAPIX Therapeutics Inc. Announces First Subjects Dosed in its First-in-Human Clinical Study of its Treg-expanding Tim3/4 Agonist LPX-TI641 to Treat Multiple Sclerosis and other Autoimmune Conditions

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable...

Ceapro Inc. Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH and Provides Update on the Scale-Up Project for its Patented Pressurized Gas eXpanded (PGX) Technology

Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization

Scientist, inventor, business expert, and holder of more than 140 patents will bring forward PUR Biologics' regenerative therapeutic patent portfolio...

Netsmart Showcases Advancements Driving Value-Based Care Success for Senior Living Providers at LeadingAge 2023

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#HealthcareIT--Netsmart, an award-winning healthcare solutions and software provider, will showcase advanced technology of the CareFabric® platform to...

error: Content is protected !!